Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Adhesive Consistency Testing in Transdermal Patches

Posted on By

SOP for Adhesive Consistency Testing in Transdermal Patches

Standard Operating Procedure for Adhesive Consistency Testing in Transdermal Patches

1) Purpose

The purpose of this SOP is to define procedures for testing the adhesive consistency of transdermal patches to ensure uniformity and adherence to quality standards.

2) Scope

This SOP applies to the adhesive consistency testing conducted on all batches of transdermal patches manufactured within the facility.

3) Responsibilities

The Quality Control (QC) Department is responsible for performing adhesive consistency testing as per this SOP. Production personnel assist in sample collection and providing necessary documentation.

4) Procedure

4.1 Sample Preparation

  • 4.1.1 Collect representative samples of transdermal patches from each batch according to approved sampling plans.
  • 4.1.2 Ensure samples are taken in a manner that preserves adhesive integrity and represents the entire batch.
See also  SOP for Product Development for New Transdermal Patch Formulations

4.2 Test Setup

  • 4.2.1 Allow transdermal patch samples to equilibrate to specified testing conditions (e.g., temperature and humidity).
  • 4.2.2 Prepare testing equipment, including a suitable apparatus for measuring adhesive properties (e.g., probe tack tester).

4.3 Adhesive Consistency Testing

  • 4.3.1 Conduct adhesive consistency tests using validated methods and equipment.
  • 4.3.2 Measure key adhesive properties, such as tackiness, peel strength, and shear strength, as applicable to product specifications.

4.4 Data Analysis

  • 4.4.1 Record test results accurately, including all measurements and observations obtained during testing.
  • 4.4.2 Compare test results against predefined acceptance criteria to determine compliance with quality standards.

4.5 Reporting and Documentation

  • 4.5.1 Document test results in the appropriate records, including batch records, testing certificates, and quality control documentation.
  • 4.5.2 Report any deviations from acceptance criteria and initiate investigation and corrective actions as required.
See also  SOP for Preservative Efficacy Testing in Transdermal Patches

5) Abbreviations, if any

SOP: Standard Operating Procedure
QC: Quality Control

6) Documents, if any

Sampling Plans
Adhesive Testing Protocols
Quality Control Records

7) Reference, if any

ISO 10993-10: Biological evaluation of medical devices – Part 10: Tests for irritation and skin sensitization
Pharmacopeial Forum: Adhesive Performance Testing

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Final Product Inspection for Transdermal Patches
Next Post: SOP for Formulation Development for Transdermal Patches

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version